JPH06508140A - 骨誘導用治療組成物 - Google Patents

骨誘導用治療組成物

Info

Publication number
JPH06508140A
JPH06508140A JP5500485A JP50048593A JPH06508140A JP H06508140 A JPH06508140 A JP H06508140A JP 5500485 A JP5500485 A JP 5500485A JP 50048593 A JP50048593 A JP 50048593A JP H06508140 A JPH06508140 A JP H06508140A
Authority
JP
Japan
Prior art keywords
bmp
vitamin
compound
effective amount
safe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP5500485A
Other languages
English (en)
Japanese (ja)
Inventor
ストーン，ロジャー　リー
Original Assignee
ザ、プロクター、エンド、ギャンブル、カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ、プロクター、エンド、ギャンブル、カンパニー filed Critical ザ、プロクター、エンド、ギャンブル、カンパニー
Publication of JPH06508140A publication Critical patent/JPH06508140A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
JP5500485A 1991-06-05 1992-05-26 骨誘導用治療組成物 Pending JPH06508140A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US709,621 1991-06-05
US85611092A 1992-03-27 1992-03-27
US856,110 1992-03-27
PCT/US1992/004356 WO1992021365A1 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Publications (1)

Publication Number Publication Date
JPH06508140A true JPH06508140A (ja) 1994-09-14

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5500485A Pending JPH06508140A (ja) 1991-06-05 1992-05-26 骨誘導用治療組成物

Country Status (13)

Country Link
EP (1) EP0587751A1 (no)
JP (1) JPH06508140A (no)
AU (1) AU667815B2 (no)
BR (1) BR9206110A (no)
CA (1) CA2110410C (no)
CZ (1) CZ282231B6 (no)
IE (1) IE921812A1 (no)
NO (1) NO934381L (no)
NZ (1) NZ243018A (no)
PT (1) PT100567A (no)
RU (1) RU2107512C1 (no)
SK (1) SK136693A3 (no)
WO (1) WO1992021365A1 (no)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012517482A (ja) * 2009-02-12 2012-08-02 ストライカー コーポレイション 障害および疾患に対する全身治療のためのＴＧＦ−βスーパーファミリーメンバー含有タンパク質の末梢投与
JP2012517483A (ja) * 2009-02-12 2012-08-02 ストライカー コーポレイション ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法
JP2014055184A (ja) * 2007-04-25 2014-03-27 Cytochroma Inc ビタミンｄ不足および欠乏症の治療方法

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
WO1993005751A2 (en) * 1991-08-30 1993-04-01 Creative Biomolecules, Inc. Osteogenic proteins in the treatment of bone deseases
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
WO1994022463A1 (en) * 1993-03-29 1994-10-13 Zymogenetics, Inc. Oesteoblast growth stimulating compostion containing pdgf and vitamin d
EP0804573A1 (en) * 1994-06-07 1997-11-05 Creative Biomolecules, Inc. Methods and compositions for modulating morphogenic protein expression
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
WO1998034655A1 (en) * 1997-02-07 1998-08-13 Stryker Corporation Matrix-free osteogenic devices, implants and methods of use thereof
CN1685055A (zh) * 2001-10-31 2005-10-19 爱尔康公司 骨形态发生蛋白(bmp)、bmp受体和bmp结合蛋白及它们在诊断和治疗青光眼中的用途
RU2595804C1 (ru) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Состав для получения стоматологической лечебно-профилактической пленки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014055184A (ja) * 2007-04-25 2014-03-27 Cytochroma Inc ビタミンｄ不足および欠乏症の治療方法
JP2012517482A (ja) * 2009-02-12 2012-08-02 ストライカー コーポレイション 障害および疾患に対する全身治療のためのＴＧＦ−βスーパーファミリーメンバー含有タンパク質の末梢投与
JP2012517483A (ja) * 2009-02-12 2012-08-02 ストライカー コーポレイション ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法

Also Published As

Publication number Publication date
AU2145492A (en) 1993-01-08
SK136693A3 (en) 1994-10-05
CZ262493A3 (en) 1994-07-13
EP0587751A1 (en) 1994-03-23
NO934381D0 (no) 1993-12-02
CZ282231B6 (cs) 1997-06-11
WO1992021365A1 (en) 1992-12-10
CA2110410C (en) 1997-04-15
BR9206110A (pt) 1995-07-11
NO934381L (no) 1994-01-31
AU667815B2 (en) 1996-04-18
NZ243018A (en) 1995-12-21
IE921812A1 (en) 1992-12-16
CA2110410A1 (en) 1992-12-10
RU2107512C1 (ru) 1998-03-27
PT100567A (pt) 1994-01-31

Similar Documents

Publication Publication Date Title
US5693615A (en) Therapeutic compositions for osteoinduction
Simion et al. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model.
JPH06508140A (ja) 骨誘導用治療組成物
US5422340A (en) TGF-βformulation for inducing bone growth
EP0679097B1 (en) Tgf-beta formulation for inducing bone growth
US7498021B2 (en) Dental products comprising bone growth enhancing peptide
US9173905B1 (en) Nutritional supplement and use thereof
Zhang et al. Berberine for bone regeneration: Therapeutic potential and molecular mechanisms
CA2222217A1 (en) Use of fibroblast growth factors mutants to stimulate bone growth
Urist et al. Regeneration of an enchondroma defect under the influence of an implant of human bone morphogenetic protein
Dorozhkin Calcium orthophosphates (CaPo4) and dentistry
AU2001283268A1 (en) Dental products comprising bone growth enhancing peptide
Kaban et al. Basic Biological Sciences Augmentation of Rat Mandibular Ridge with Demineralized Bone Implants
Abd Elrahman et al. Evaluation of Nigella sativa on socket healing in rabbits
JP2003095974A (ja) 骨形成を安全に促進させる医薬複合剤
FH Jr et al. Effect of calcitonin on bone healing following titanium implant insertion
Jaron et al. The application of bone morphogenetic proteins in medicine, dentistry, sport and rehabilitation: A review of literature
Um et al. Clinical Application of DDM/rhBMP-2 in implant dentistry
Aghaloo et al. Growth Factors for Site Preparation: Current Science, Indications, and Practice
Aghaloo et al. Growth Factors for Site Preparation: Current Science, Indications
Shaikh To Compare Efficacy of Platelet Rich Fibrin in Combination with Demineralized Freeze Dried Bone Allograft & Demineralized Freeze Dried Bone Allograft Alone in the Treatment of Intra Bony Defects”: A Clinico-Radiographic Study
Abdelraheim et al. Comparative Study of Autogenous Fresh Tooth Graft and Platelet Rich Fibrin Mixture versus Autogenous Fresh Tooth Graft Only For Immediate Dental Implant Placement
Sonobe et al. Bone Morphogenetic Proteins~ BMP-2 and BMP-7
FR2781376A1 (fr) Composition protectrice et regulatrice de l'homeostasie de la masse osseuse contenant des polymeres ou biopolymeres et leurs utilisations
da Escóssia et al. JOURNALOFDENTALANDORA LIMPLANTS